Zolmitriptan Tablet, Orally Disintegrating
Product Images NDC 68382-715

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 68382-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 01

Chemical structure diagram of zolmitriptan, showing its molecular framework with characteristic rings and side chains.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 02

Line graph depicting the estimated probability of response over time from initial dose up to 4 hours, comparing placebo and zolmitriptan at 1 mg, 2.5 mg, and 5 mg doses. The probability increases over time for all zolmitriptan doses with higher doses showing greater probabilities than placebo.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 03

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for placebo and zolmitriptan doses of 1 mg, 2.5 mg, and 5 mg. The graph indicates increasing probability over 24 hours with distinct trajectories for each dose.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 04

A line graph showing the estimated probability of response over time from the initial dose comparing Zolmitriptan 2.5 mg orally disintegrating tablet (ODT) versus placebo. The x-axis represents time in hours, and the y-axis represents the percentage probability of response, with Zolmitriptan showing a higher response rate over 2 hours compared to placebo.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 05

A graph comparing the estimated probability of response over 24 hours between placebo and Zolmitriptan ODT 2.5 mg tablets. The x-axis shows time from initial dose in hours, and the y-axis shows the estimated probability of response in percentages, illustrating higher response likelihood for Zolmitriptan compared to placebo.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 06

Label for Zolmitriptan Orally Disintegrating Tablets USP, 2.5 mg strength. The label shows the tablet imprint "715" and indicates a package size of 30 tablets. Labeler is Zydus Pharmaceuticals USA Inc. The label includes storage instructions, phenylketonurics warning, and notes that the tablets are prescription only (Rx only).*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 07

The image shows labels for Zolmitriptan Orally Disintegrating Tablets, USP, with a strength of 2.5 mg. Each label includes a barcode and states the product is made in India and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. Space for lot number and expiration date is provided. The labels are arranged in a grid pattern.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 08

Packaging label for Zolmitriptan Orally Disintegrating Tablets, USP, 2.5 mg strength by Zydus Pharmaceuticals USA Inc. The label indicates the product is an orally disintegrating tablet with each tablet containing 2.5 mg of zolmitriptan. The package contains unit-dose tablets with a total count of 6 tablets (1x6). It includes storage instructions and safety warnings, as well as manufacturer and distributor details.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 09

Label for Zolmitriptan Orally Disintegrating Tablets, USP, 5 mg strength. The label includes the NDC 68382-717-06 and displays the tablet shape and imprint '717'. It is marketed by Zydus Pharmaceuticals USA Inc. and indicates a package size of 30 tablets, oral route, Rx only. The label contains usage instructions and storage information.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 10

The image shows packaging labels for Zolmitriptan Orally Disintegrating Tablets, USP, each with a strength of 5 mg. The labels include the product name, dosage form, and strength prominently, along with barcodes. They state the product is made in India and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, with fields for lot and expiration date.*

FDA Label Image

452d6de3 E6fa 4405 A03b 9b15ef2bd39e 11

Packaging label for Zolmitriptan Orally Disintegrating Tablets, USP, 5 mg strength. The label shows unit-dose tablets with packaging instructions, storage conditions, and a note to keep drugs out of reach of children. Manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label includes the NDC 68382-717-82 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.